{
    "code": "02025197",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025197",
    "time": "2015-11-13 03:33:07",
    "許可證字號": "衛署藥輸字第025197號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/05\/31",
    "發證日期": "99\/05\/31",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202519700",
    "中文品名": "道樂160 毫克膜衣錠",
    "英文品名": "Tareg 160mg Film Coated Tablets",
    "適應症": "高血壓、心衰竭(HYHA二到四級)、心肌梗塞後左心室功能異常。",
    "劑型": "116膜衣錠",
    "包裝": "2~1000錠鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "VALSARTAN",
    "限制項目": [
        "01國產",
        "24監視期滿學名藥"
    ],
    "申請商名稱": "1304601100  瑞士商愛爾康大藥廠股份有限公司台灣分公司",
    "申請商地址": "新北市新店區寶中路119號四樓",
    "主製造廠": {
        "製造廠名稱": "F410106000  NOVARTIS FARMACEUTICA S.A.",
        "製造廠廠址": "RONDA SANTA MARIA, 158, 08210 BARBERA DEL VALLES (BARCELONA), SPAIN",
        "製造廠公司地址": "",
        "製造廠國別": "SPAIN",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2408005100",
            "成分名稱": "VALSARTAN",
            "含量描述": "",
            "含量": "160.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "02-025197-0001_TWI-020615-104-08-21.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025197&Seq=005&Type=9"
        },
        {
            "title": "rfp 1115683 Tareg 160mg_LFT P5___20110712.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025197&Seq=004&Type=9"
        },
        {
            "title": "rfp 1115683 Tareg 160mg_LFT P5___20110707.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025197&Seq=003&Type=9"
        },
        {
            "title": "020251970002___20100826.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025197&Seq=002&Type=9"
        },
        {
            "title": "020251970001___20100826.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025197&Seq=001&Type=9"
        },
        {
            "title": "02-025197-0003_FL-104-08-21.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025197&Seq=009&Type=8"
        },
        {
            "title": "02-025197-0002_FB-104-08-21.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025197&Seq=008&Type=8"
        },
        {
            "title": "rfp 1115664 Tareg 160mg___20110707.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025197&Seq=007&Type=8"
        },
        {
            "title": "rfp 1115662 Tareg 160mg_Foil_4 proof___20110712.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025197&Seq=006&Type=8"
        },
        {
            "title": "rfp 1115662 Tareg 160mg_Foil_4 proof___20110707.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025197&Seq=005&Type=8"
        },
        {
            "title": "1115664 Tareg 160mg___20110712.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025197&Seq=004&Type=8"
        },
        {
            "title": "020251970003___20100826.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025197&Seq=003&Type=8"
        },
        {
            "title": "020251970002___20100826.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025197&Seq=002&Type=8"
        },
        {
            "title": "020251970001___20100826.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025197&Seq=001&Type=8"
        }
    ]
}